This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Demyelinating diseases of the central nervous system
G6_DEMYEL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
3650 |
6. Filter based on genotype QC (FinnGen only) |
3650 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Demyelinating diseases of the central nervous system
based on the number of shared cases.
Similar with more cases:
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3650 | 2678 | 972 |
| Unadjusted period prevalence (%) | 0.78 | 0.91 | 0.43 |
| Median age at first event (years) | 38.19 | 36.94 | 41.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3291
- Matched controls
- 32908
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L03AB08
ATC
interferon beta-1b; parenteral
+∞
323.0
382
*
TAB00
NOMESCO Finland
Lumbar puncture
22.9
323.0
1052
660
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
+∞
323.0
1579
*
353
Kela drug reimbursment
Cladribine and fingolimod
+∞
323.0
386
*
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
323.0
1503
*
N04BB01
ATC
amantadine; oral
57.3
323.0
518
107
L04AA27
ATC
fingolimod; oral
+∞
323.0
321
*
109
Kela drug reimbursment
Multiple sclerosis
+∞
323.0
1876
*
L04AX07
ATC
dimethyl fumarate; oral
+∞
323.0
510
*
G35
ICD-10 Finland
Multiple sclerosis
15871.4
323.0
2679
6
L04AA31
ATC
teriflunomide; oral
+∞
323.0
408
*
L03AX13
ATC
glatiramer acetate; parenteral
+∞
323.0
672
*
164
Kela drug reimbursment
Fingolimod
+∞
323.0
438
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
20.3
323.0
1443
1218
H46
ICD-10 Finland
Optic neuritis
178.2
323.0
735
53
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
14605.3
323.0
1027
*
N07XX09
ATC
[U] dimethyl fumarate; oral
+∞
323.0
333
*
N86
ICPC
Multiple sclerosis
2009.4
323.0
764
5
L03AB07
ATC
interferon beta-1a; parenteral
+∞
323.0
867
*
M03BX01
ATC
baclofen; systemic
29.2
318.3
438
172
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
+∞
249.2
236
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
31.2
245.9
332
118
XA800
NOMESCO Finland
Neuropsychological investigation
10.6
222.2
455
489
2AB04
NOMESCO Finland
NA
173.2
216.8
226
14
R20.2
ICD-10 Finland
Paraesthesia of skin
6.3
215.4
633
1196
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
15.2
213.9
367
269
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
+∞
210.7
200
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.7
197.1
626
1293
XKD06
NOMESCO Finland
Physiologic investigation of micturition
13.8
193.4
346
278
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.4
191.6
639
1395
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
191.5
182
*
XCK00
NOMESCO Finland
Perimetry
6.9
172.6
464
763
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.8
168.6
848
2747
G04BD09
ATC
trospium; oral
15.7
165.9
280
194
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
16.3
165.6
275
183
G04BD12
ATC
mirabegron; oral
5.5
161.9
525
1093
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
10.4
159.9
329
349
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.4
152.8
436
771
34099
ICD-8 Finland
Multiple sclerosis
+∞
152.3
145
*
XKD00
NOMESCO Finland
Uroflowmetry
4.5
141.4
562
1444
L03AB13
ATC
peginterferon beta-1a; parenteral
+∞
140.6
134
*
ZX120
NOMESCO Finland
Intravenous
4.4
139.4
560
1452
N03AX12
ATC
gabapentin; oral
3.4
132.4
763
2688
G04BD04
ATC
oxybutynin; oral, transdermal
6.8
128.8
345
555
N06BA07
ATC
modafinil; oral
50.0
126.1
153
32
N03AE01
ATC
clonazepam; systemic
5.2
119.9
404
863
XKC03
NOMESCO Finland
Water cystometry
8.9
118.0
263
318
H53.2
ICD-10 Finland
Diplopia
8.7
112.4
254
314
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
16.4
112.3
185
119
4AA23
NOMESCO Finland
NA
550.6
108.4
107
*
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
106.8
102
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
9.2
105.4
229
264
UKC02
NOMESCO Finland
Cystoscopy
3.4
103.1
564
1875
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
26.1
103.0
145
58
R1250
NOMESCO Finland
Evaluation of functional capability
9.4
100.8
216
243
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.8
96.9
352
808
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
+∞
96.3
92
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
20.6
93.8
142
72
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.9
92.2
419
1189
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
+∞
88.9
85
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
9.1
88.6
193
223
G04BD07
ATC
tolterodine; oral
5.9
88.5
262
475
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
24.6
84.7
121
51
N03AX16
ATC
pregabalin; oral
2.4
81.8
883
4403
TKC22
NOMESCO Finland
Catheterisation instruction
10.8
81.8
162
157
L04AA40
ATC
cladribine; oral
+∞
79.5
76
*
G04BD08
ATC
solifenacin; oral
4.4
78.2
303
738
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
22.1
73.9
109
51
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
14.4
72.9
126
91
R35
ICD-10 Finland
Polyuria
4.5
72.7
277
662
SPAT1229
SPAT
Assessment of need for aid
4.0
72.0
313
847
N29
ICPC
Neurological sympt/complt other
9.0
70.9
155
180
H02AB04
ATC
methylprednisolone; systemic
2.6
70.1
600
2616
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.1
68.3
407
1412
L28
ICPC
Limited function/disability (L)
2.7
65.0
487
1959
J01EA01
ATC
trimethoprim; systemic
2.1
64.9
956
5398
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
47.5
64.8
79
17
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
63.5
557
2450
R33
ICD-10 Finland
Retention of urine
4.2
63.4
259
660
N28
ICPC
Limited function/disability (N)
10.9
60.7
119
113
G37.2
ICD-10 Finland
Central pontine myelinolysis
+∞
58.5
56
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.3
57.3
314
1020
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
5.7
56.3
170
314
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
56.2
921
5367
XCD10
NOMESCO Finland
Electrophysiological examination of eye
6.3
55.8
154
254
N05CF01
ATC
zopiclone; oral
1.9
55.6
995
5992
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.0
55.4
237
629
TKC20
NOMESCO Finland
Catheterisation of bladder
3.7
55.4
258
737
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
6.7
55.1
145
224
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
54.8
297
956
3419X
ICD-9 Finland
Other demyelinating diseases of central nervous system, Demyelinating disease of central nervous system, unspecified
+∞
54.3
52
*
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
35.7
54.3
70
20
36703
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris
189.8
54.1
56
*
XKD03
NOMESCO Finland
Urethral pressure profilometry
6.5
53.8
146
235
G04BD11
ATC
fesoterodine; oral
6.2
52.8
147
245
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
33.0
51.8
68
21
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.1
51.4
302
1029
H53.1
ICD-10 Finland
Subjective visual disturbances
3.2
50.8
287
951
N99
ICPC
Neurological disease other
9.8
50.5
104
109
L04AX01
ATC
azathioprine; systemic
3.7
50.3
232
656
G37.8
ICD-10 Finland
Other specified demyelinating diseases of central nervous system
+∞
49.1
47
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.1
48.6
159
322
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
33.8
48.3
63
19
L01BB04
ATC
cladribine; systemic
+∞
48.0
46
*
R4110
NOMESCO Finland
Physiotherapy
1.9
47.9
834
4918
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
10.8
47.6
93
88
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
47.4
476
2217
R4150
NOMESCO Finland
Neuropsychological rehabilitation
10.6
47.1
93
90
H47.2
ICD-10 Finland
Optic atrophy
33.9
46.1
60
18
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.0
45.8
291
1042
SPAT1231
SPAT
Assessment of adjustments needed in living environment
8.8
45.6
100
117
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
45.6
210
593
R42
ICD-10 Finland
Dizziness and giddiness
2.0
45.1
651
3558
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
12.1
45.0
83
70
N03AF01
ATC
carbamazepine; oral, rectal
3.4
44.4
225
686
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
17.0
43.8
70
42
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
9.6
43.3
90
96
34109
ICD-8 Finland
Other demyelinating diseases of central nervous system, Unspecified
+∞
41.7
40
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
5.3
41.2
131
257
4AA36
NOMESCO Finland
NA
+∞
40.7
39
*
SPAT1216
SPAT
Assessment of functional ability
2.3
40.2
404
1876
3773B
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]
402.3
40.2
40
*
R4120
NOMESCO Finland
Occupational therapy
2.9
39.6
256
924
C10AC01
ATC
colestyramine; oral
4.5
39.5
145
332
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
11.3
39.4
75
68
A28
ICPC
Limited function/disability NOS
2.5
39.1
337
1446
AA1AD
NOMESCO Finland
CT of head and brain
1.9
35.6
619
3595
CS494
NOMESCO Finland
Other visual field testing
5.6
35.2
105
192
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
12.3
34.7
63
52
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
93.6
33.8
37
*
H02AB07
ATC
prednisone; oral
2.0
33.5
455
2402
N06AA09
ATC
amitriptyline; systemic
2.3
33.4
332
1526
G50.0
ICD-10 Finland
Trigeminal neuralgia
5.6
33.4
100
184
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
33.3
1111
7846
N30.0
ICD-10 Finland
Acute cystitis
2.0
33.1
473
2547
N06AX16
ATC
venlafaxine; oral
1.9
33.0
557
3191
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
17.0
32.8
52
31
J01CA08
ATC
pivmecillinam; oral
1.6
32.7
1429
10802
RF120
NOMESCO Finland
NA
6.5
32.2
85
133
A02BC02
ATC
pantoprazole; systemic
1.6
32.1
1932
15728
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
10.7
31.4
61
58
N04BD01
ATC
selegiline; oral
8.6
31.4
69
82
N04BC05
ATC
pramipexole; oral
2.7
30.7
223
867
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
15.4
30.4
50
33
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
6.6
30.3
79
122
A06AD11
ATC
lactulose; oral
2.1
30.2
361
1804
U13
ICPC
Bladder symptom/complaint other
4.0
30.0
122
310
N03AF02
ATC
oxcarbazepine; oral
3.4
28.7
142
425
M03BX02
ATC
tizanidine; oral
1.5
28.7
2057
17202
G82.2
ICD-10 Finland
Paraplegia, unspecified
15.4
28.6
47
31
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
28.5
320
1555
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
28.1
412
2232
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.6
28.0
208
817
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
16.5
27.5
44
27
N06AX21
ATC
duloxetine; oral
2.0
27.5
397
2137
Z43.5
ICD-10 Finland
Attention to cystostomy
21.3
27.4
40
19
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
9.3
26.9
56
61
J01XX05
ATC
methenamine; oral
9.2
26.7
56
62
F02.89
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without information of additional symptoms
141.1
26.6
28
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
6.7
26.3
68
104
R03CA02
ATC
ephedrine; oral
52.1
26.2
31
6
H53.4
ICD-10 Finland
Visual field defects
4.9
26.1
87
182
L89
ICD-10 Finland
Decubitus ulcer and pressure area
6.5
25.8
68
107
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
25.3
322
1647
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.3
25.2
95
225
G04CA02
ATC
tamsulosin; oral
2.0
25.0
353
1883
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.6
24.7
185
730
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
24.5
575
3633
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
24.5
645
4212
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.9
24.1
152
542
H48.1
ICD-10 Finland
Retrobulbar neuritis in diseases classified elsewhere
+∞
24.0
23
*
G37.0
ICD-10 Finland
Diffuse sclerosis
+∞
24.0
23
*
SPAT1167
SPAT
Insertion of urinary catheter
4.5
24.0
87
199
Z50.1
ICD-10 Finland
Other physical therapy
2.7
23.9
174
677
N18
ICPC
Paralysis/weakness
5.5
23.2
69
127
J01MA02
ATC
ciprofloxacin; systemic
1.5
23.1
1044
7770
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
23.0
324
1722
G36.8
ICD-10 Finland
Other specified acute disseminated demyelination
+∞
22.9
22
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
8.0
22.9
52
66
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
22.9
789
5510
U04
ICPC
Incontinence urine
3.0
22.6
135
462
R39.1
ICD-10 Finland
Other difficulties with micturition
3.8
22.6
97
260
N06AB04
ATC
citalopram; systemic
1.6
22.2
675
4566
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
21.7
267
1346
H57.1
ICD-10 Finland
Ocular pain
2.8
21.2
137
494
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
20.9
286
1503
U07
ICPC
Urine symptom/complaint other
2.5
20.9
171
709
R20.1
ICD-10 Finland
Hypoaesthesia of skin
7.9
20.7
47
60
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.7
20.7
71
154
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.3
20.7
108
339
RS221
NOMESCO Finland
NA
4.5
20.5
73
165
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
20.1
319
1771
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
20.1
637
4341
G04BD01
ATC
emepronium; systemic
8.5
19.9
43
51
U05
ICPC
Urination problems other
2.9
19.7
125
448
R51.80
ICD-10 Finland
Headache
1.6
19.7
510
3298
U28
ICPC
Limited function/disability (U)
8.8
19.3
41
47
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.4
19.2
161
677
G04BE03
ATC
sildenafil; oral
7.1
18.8
46
66
RF420
NOMESCO Finland
NA
4.2
18.8
72
175
34108
ICD-8 Finland
Other demyelinating diseases of central nervous system, Alii definiti
+∞
18.8
18
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.1
18.7
103
337
R20.0
ICD-10 Finland
Anaesthesia of skin
6.5
18.5
48
75
RF410
NOMESCO Finland
NA
4.7
18.4
63
137
G04BD10
ATC
darifenacin; oral
9.6
18.3
37
39
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
12.4
18.1
32
26
G04BDXX
ATC
NA
14.4
18.1
30
21
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
18.0
708
5055
H02AB06
ATC
prednisolone; systemic
1.4
17.8
1287
10360
G37.1
ICD-10 Finland
Central demyelination of corpus callosum
+∞
17.7
17
*
Z93.5
ICD-10 Finland
Cystostomy status
67.0
17.7
20
*
G61.0
ICD-10 Finland
Guillain-Barré syndrome
11.1
17.7
33
30
N07AA02
ATC
pyridostigmine; systemic
9.3
17.6
36
39
N06AX11
ATC
mirtazapine; oral
1.4
17.4
916
6945
N87
ICPC
Parkinsonism
7.4
17.4
41
56
6BA02
NOMESCO Finland
NA
10.1
17.4
34
34
XCK10
NOMESCO Finland
Photography of fundus of eye
2.0
17.3
238
1253
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
17.2
181
853
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
17.2
336
1994
G70.0
ICD-10 Finland
Myasthenia gravis
11.1
17.2
32
29
R15
ICD-10 Finland
Faecal incontinence
3.4
17.2
82
242
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
11.6
17.0
31
27
M05BA04
ATC
alendronic acid; oral
2.3
16.9
156
691
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
16.7
1086
8549
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
16.7
297
1712
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
16.6
291
1671
R32
ICD-10 Finland
Unspecified urinary incontinence
3.2
16.3
87
279
N02BE01
ATC
paracetamol; systemic, rectal
1.4
16.3
2614
23954
RF432
NOMESCO Finland
NA
40.3
16.3
20
5
N07AA03
ATC
distigmine; systemic
14.3
16.3
27
19
WW400
NOMESCO Finland
Plasmaferesis
14.3
16.3
27
19
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
14.3
16.3
27
19
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.9
16.0
66
173
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
15.8
320
1923
RS340
NOMESCO Finland
NA
11.2
15.7
29
26
SPAT1262
SPAT
Handing over of treatment supplies
1.6
15.7
428
2796
N03AX09
ATC
lamotrigine; oral
2.1
15.7
192
965
J01XE01
ATC
nitrofurantoin; oral
3.3
15.6
79
244
U29
ICPC
Urinary symptom/complaint other
3.2
15.6
81
255
J01MA06
ATC
norfloxacin; oral
1.6
15.6
389
2482
359
Kela drug reimbursment
Mirabegroni
8.5
15.4
33
39
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.6
15.4
111
432
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
4.0
15.2
60
151
G51.0
ICD-10 Finland
Bell palsy
2.9
15.1
92
323
S97
ICPC
Chronic ulcer skin
2.5
14.9
120
497
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.8
14.9
63
169
RS222
NOMESCO Finland
NA
4.4
14.7
53
123
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.5
14.6
111
446
3773A
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[PAPILLITIS OPTICA]
+∞
14.6
14
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.0
14.6
83
277
G04CA01
ATC
alfuzosin; oral
2.0
14.6
188
965
ABD40
NOMESCO Finland
Implantation of spinal injection device
36.2
14.4
18
5
R27.0
ICD-10 Finland
Ataxia, unspecified
9.4
14.4
29
31
G04BE01
ATC
alprostadil; parenteral, urethral
5.9
14.2
39
67
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.6
14.1
63
177
K59.0
ICD-10 Finland
Constipation
2.2
13.9
137
628
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
7.8
13.8
31
40
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
13.7
278
1670
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.4
13.7
66
198
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.1
13.6
42
83
RS121
NOMESCO Finland
NA
5.7
13.6
38
67
J01MA12
ATC
levofloxacin; systemic
1.5
13.6
437
2966
R13
ICD-10 Finland
Dysphagia
2.1
13.5
158
780
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
13.5
144
684
J01DB01
ATC
cefalexin; oral
1.4
13.4
2530
23270
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
4.6
13.4
46
102
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.6
13.2
58
162
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
13.1
225
1282
N30.9
ICD-10 Finland
Cystitis, unspecified
2.0
13.0
168
863
SPAT1263
SPAT
Sampling
1.3
13.0
1200
9900
G97.1
ICD-10 Finland
Other reaction to spinal and lumbar puncture
10.1
13.0
25
25
R60.0
ICD-10 Finland
Localized oedema
1.8
12.9
245
1441
N06
ICPC
Sensation disturbance other
4.2
12.8
47
112
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
12.8
68
220
RS130
NOMESCO Finland
NA
10.5
12.7
24
23
H30.2
ICD-10 Finland
Posterior cyclitis
9.7
12.7
25
26
R47.1
ICD-10 Finland
Dysarthria and anarthria
6.0
12.7
34
57
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.1
12.6
152
759
N02AX02
ATC
tramadol; systemic, rectal
1.3
12.6
1062
8633
XA412
NOMESCO Finland
VEP
70.1
12.6
14
*
108
Kela drug reimbursment
Myasthenia gravis
11.0
12.5
23
21
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
12.5
382
2560
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
20.1
12.4
18
9
U08
ICPC
Urinary retention
4.4
12.3
43
98
Z73.6
ICD-10 Finland
Limitation of activities due to disability
5.9
12.2
33
56
NA1BM
NOMESCO Finland
Cervical spine MRI examination with 3 Tesla magnet
9.7
12.2
24
25
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.3
12.2
115
517
SPAT1301
SPAT
No procedures
1.4
12.1
792
6173
N05BA01
ATC
diazepam; systemic, rectal
1.6
12.1
343
2257
R53
ICD-10 Finland
Malaise and fatigue
1.4
12.0
542
3949
U02
ICPC
Urinary frequency/urgency
1.6
12.0
334
2188
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.1
11.9
65
215
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.9
11.7
164
868
XA402
NOMESCO Finland
ENMG
2.6
11.7
82
317
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
11.6
159
836
SPAT1325
SPAT
Vaccination
1.4
11.6
794
6230
N07AB01
ATC
carbachol; systemic
10.1
11.5
22
22
G04BD
ATC
Drugs for urinary frequency and incontinence
10.1
11.5
22
22
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
5.7
11.5
32
57
ZXA10
NOMESCO Finland
Bilateral
1.5
11.4
427
2995
RF122
NOMESCO Finland
NA
11.8
11.3
20
17
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
11.3
1144
9515
36702
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica. Papillitis
35.1
11.3
14
*
G61.9
ICD-10 Finland
Inflammatory polyneuropathy, unspecified
10.6
11.2
21
20
J05AB11
ATC
valaciclovir; oral
1.5
11.2
370
2523
G20
ICD-10 Finland
Parkinson disease
3.1
11.1
60
197
F05
ICPC
Visual disturbance other
2.8
11.1
69
246
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
20.1
11.1
16
8
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.0
11.1
136
686
U71
ICPC
Cystitis/urinary infection other
1.9
11.0
168
923
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
13.9
11.0
18
13
J01MA01
ATC
ofloxacin; systemic
1.8
10.9
202
1181
N03AX14
ATC
levetiracetam; systemic
2.6
10.8
79
311
WX110
NOMESCO Finland
Local anesthesy
1.3
10.7
2121
19227
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
21.5
10.7
15
7
R5110
SPAT
NA
2.8
10.6
68
250
C03CA01
ATC
furosemide; systemic
1.5
10.6
441
3160
SPAT1260
SPAT
Consultation of another employee
1.5
10.5
437
3127
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
10.5
280
1814
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
10.1
10.5
20
20
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
9.2
10.5
21
23
N06AB10
ATC
escitalopram; oral
1.4
10.5
650
5010
H52.1
ICD-10 Finland
Myopia
2.1
10.4
113
541
G36.1
ICD-10 Finland
Acute and subacute haemorrhagic leukoencephalitis [Hurst]
+∞
10.4
10
*
R5599
NOMESCO Finland
Other rehabilitation service
2.5
10.3
80
327
G96.9
ICD-10 Finland
Disorder of central nervous system, unspecified
18.8
10.2
15
8
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
10.2
1654
14571
R52.2
ICD-10 Finland
Other chronic pain
2.2
10.2
97
441
G83.1
ICD-10 Finland
Monoplegia of lower limb
13.1
10.1
17
13
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
10.1
980
8080
WX892
NOMESCO Finland
Monitored bed care
1.8
10.0
160
892
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
10.0
391
2765
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
4.4
10.0
35
81
M48.0
ICD-10 Finland
Spinal stenosis
1.7
9.8
211
1289
AAH30
NOMESCO Finland
Thermal destruction of cranial nerve
26.1
9.8
13
5
R31
ICD-10 Finland
Unspecified haematuria
1.8
9.6
171
987
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
9.5
163
929
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
9.5
775
6219
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
9.5
142
776
G04.0
ICD-10 Finland
Acute disseminated encephalitis
100.3
9.4
10
*
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
17.6
9.4
14
8
3418X
ICD-9 Finland
Other demyelinating diseases of central nervous system
+∞
9.4
9
*
L17
ICPC
Foot/toe symptom/complaint
1.4
9.1
601
4667
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
9.1
78
338
W19
ICD-10 Finland
Unspecified fall
1.6
9.0
208
1296
SPAT1234
SPAT
Support of social functional capacity
2.0
9.0
105
523
RF210
NOMESCO Finland
NA
2.2
9.0
88
405
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
9.0
199
1227
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.2
9.0
32
76
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.6
9.0
63
247
J05AB01
ATC
aciclovir; systemic
1.4
8.9
586
4543
G44.2
ICD-10 Finland
Tension-type headache
1.4
8.9
391
2823
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
8.9
305
2093
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
5.7
8.9
24
42
RF312
NOMESCO Finland
NA
12.5
8.9
15
12
SPAT1254
SPAT
Administration of medicine
1.5
8.8
319
2220
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
4.6
8.8
29
64
N27
ICPC
Fear of neurological disease other
3.8
8.7
35
93
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
8.6
674
5368
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.5
8.5
62
246
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
8.5
1769
15908
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
12.8
8.4
14
11
G37.5
ICD-10 Finland
Concentric sclerosis [Baló]
+∞
8.3
8
*
R1260
NOMESCO Finland
Evaluation of communicative skills
3.4
8.3
38
113
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
7.1
8.2
19
27
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.5
8.2
36
103
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.5
8.2
60
239
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
3.7
8.2
34
93
R11
ICD-10 Finland
Nausea and vomiting
1.6
8.2
196
1238
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
8.1
161
2476
RF310
NOMESCO Finland
NA
6.0
8.1
21
35
A02BA02
ATC
ranitidine; systemic
1.4
8.1
441
3315
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.4
8.1
37
110
NA1AG
NOMESCO Finland
Restricted MRI of cervical spine
33.4
8.1
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
8.0
880
7322
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.8
8.0
126
699
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
3.6
8.0
34
95
G04BE08
ATC
tadalafil; oral
22.1
8.0
11
5
1DB07
NOMESCO Finland
NA
22.1
8.0
11
5
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
5.3
8.0
23
44
XKX00
NOMESCO Finland
Pelvic floor electromyography
6.1
7.8
20
33
M54.1
ICD-10 Finland
Radiculopathy
1.9
7.8
102
533
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.5
7.8
34
98
D21
ICPC
Swallowing problem
3.8
7.7
31
83
TKC10
SPAT
NA
45.1
7.7
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
7.7
436
3301
A29
ICPC
General symptom/complaint other
1.5
7.7
238
1602
SPAT1281
SPAT
Other administrative function
1.6
7.6
203
1315
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.1
7.6
40
132
H53.8
ICD-10 Finland
Other visual disturbances
3.4
7.6
35
105
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.6
1129
9731
R25.2
ICD-10 Finland
Cramp and spasm
2.5
7.6
57
233
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
2.9
7.6
42
144
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
7.6
1450
12854
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
7.6
313
2235
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
10.0
7.5
14
14
RS142
NOMESCO Finland
NA
7.1
7.5
17
24
R83.4
ICD-10 Finland
Abnormal findings in cerebrospinal fluid, Abnormal immunological findings
80.3
7.4
8
*
1601
FHL
Cystometry
80.3
7.4
8
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
7.4
2194
20344
M05BX04
ATC
denosumab; parenteral
2.1
7.4
84
415
J01AA02
ATC
doxycycline; systemic
1.2
7.4
2275
21181
RS230
NOMESCO Finland
NA
4.6
7.4
24
53
H50.52
ICD-10 Finland
Exophoria
3.0
7.3
40
136
M79.6
ICD-10 Finland
Pain in limb
1.3
7.3
941
7970
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.7
7.3
148
892
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
3.4
7.3
33
98
4AA34
NOMESCO Finland
NA
+∞
7.3
7
*
H01AA02
ATC
tetracosactide; parenteral
+∞
7.3
7
*
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
7.3
66
295
J01DA01
ATC
[U] cefalexin; systemic
1.2
7.3
1836
16723
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
7.2
1019
8722
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
7.2
1999
18379
A06AC51
ATC
ispaghula, combinations; systemic
1.8
7.2
113
629
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.6
7.1
47
180
R26.0
ICD-10 Finland
Ataxic gait
7.9
7.1
15
19
K02.1
ICD-10 Finland
Caries of dentine
1.2
7.1
1735
15730
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
5.3
7.1
20
38
L19
ICPC
Muscle symptom/complaint NOS
2.3
7.0
62
275
RF214
NOMESCO Finland
NA
10.0
7.0
13
13
E0000UV
ATC
NA
1.2
6.9
1094
9472
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
6.9
842
7079
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
6.9
55
232
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
6.9
434
3336
R30.0
ICD-10 Finland
Dysuria
1.9
6.9
91
479
D82
ICPC
Teeth/gum disease
1.2
6.8
1017
8744
D17
ICPC
Incontinence of bowel
4.8
6.8
21
44
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.6
6.8
188
1231
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
6.7
6.8
16
24
R4130
NOMESCO Finland
Speech therapy
2.4
6.8
52
216
SPAT1172
SPAT
Guidance concerning hydration
2.8
6.8
40
143
34409
ICD-8 Finland
Other cerebral paralysis, Unspecified
40.1
6.8
8
*
A46
ICD-10 Finland
Erysipelas
1.5
6.7
246
1717
SPAT1104
SPAT
Monitoring of emergency patient
1.7
6.7
141
860
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
6.7
433
3339
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
6.7
338
2502
K59.01
ICD-10 Finland
Constipation outlet obstruction type
3.2
6.7
33
105
K07
ICPC
Swollen ankles/oedema
2.0
6.7
75
371
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
4.1
6.7
24
59
H81.4
ICD-10 Finland
Vertigo of central origin
4.4
6.6
22
50
H20.1
ICD-10 Finland
Chronic iridocyclitis
3.1
6.6
34
112
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.8
6.6
101
561
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
6.6
276
1978
R30.1
ICD-10 Finland
Vesical tenesmus
2.6
6.6
44
170
R20.8
ICD-10 Finland
Other and unspecified disturbances of skin sensation
3.0
6.6
35
118
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
2.6
6.5
44
171
U01
ICPC
Dysuria/painful urination
1.5
6.5
188
1244
SPAT1211
SPAT
Application of soft bandage
1.5
6.5
194
1297
W10
ICD-10 Finland
Fall on and from stairs and steps
1.8
6.5
111
639
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.0
6.5
75
375
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
3.8
6.5
25
66
L29
ICPC
Musculoskeletal sympt/complt other
1.6
6.4
173
1126
R06.0
ICD-10 Finland
Dyspnoea
1.3
6.4
525
4192
E87.6
ICD-10 Finland
Hypokalaemia
2.1
6.4
66
316
B02.9
ICD-10 Finland
Zoster without complication
1.8
6.4
108
618
MA3AE
NOMESCO Finland
Combined first trimester screening
0.5
6.4
41
848
N86
ICD-10 Finland
Erosion and ectropion of cervix uteri
4.9
6.3
19
39
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.9
6.3
85
452
A04AA55
ATC
palonosetron, combinations; systemic
0.3
6.3
15
460
183
Kela drug reimbursment
Lamotrigin and topiramate
2.8
6.3
37
132
Z01.2
ICD-10 Finland
Dental examination
1.2
6.3
1198
10552
RF433
NOMESCO Finland
NA
9.3
6.3
12
13
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.0
6.3
78
402
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
6.3
1556
14059
N30
ICD-10 Finland
Cystitis
1.5
6.2
198
1341
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
6.2
259
1855
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.6
6.2
144
907
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.8
6.2
383
4860
H52.2
ICD-10 Finland
Astigmatism
2.5
6.1
42
166
SPAT1360
SPAT
Extensive global examination
1.6
6.1
154
988
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
2.5
6.1
45
185
N30.8
ICD-10 Finland
Other cystitis
3.5
6.1
26
75
A02BA04
ATC
nizatidine; systemic
1.6
6.1
149
948
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.6
6.1
40
153
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
6.1
1615
14665
34400
ICD-8 Finland
Other cerebral paralysis, Hemiplegia NUD
12.5
6.1
10
8
U72
ICPC
Urethritis
2.2
6.1
59
277
N02AA05
ATC
oxycodone; systemic
1.4
6.1
247
1762
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.2
6.1
58
269
A08
ICPC
Swelling
1.9
6.0
78
407
T83.0
ICD-10 Finland
Mechanical complication of urinary (indwelling) catheter
10.0
6.0
11
11
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
10.0
6.0
11
11
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
6.0
2862
27555
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.3
6.0
50
218
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
261
160
17.49
313.16
1.1
1.1
1695.1
1539.7
miu/ml
0.78
261
160
2512
13437
3.79
309.69
12.6
5.9
0.8
0.7
%
10.43
2459
12599
2729
15438
4.04
308.05
13.0
6.0
0.2
0.2
e9/l
0.11
2541
13809
770
731
13.08
307.65
1.2
1.3
426.9
503.8
mg/l
3.26
742
691
367
198
20.50
307.65
2.8
1.9
15.1
12.5
%
2.11
179
98
286
191
16.16
307.65
4.5
2.3
976.0
716.1
e6/l
3.36
186
67
727
485
18.47
307.65
1.2
1.1
—
—
—
0
0
684
224
37.35
307.65
1.1
1.1
—
—
—
0
0
581
290
23.64
307.65
1.1
1.1
—
—
—
0
0
1190
2208
7.51
307.65
3.5
2.6
10.0
10.6
g/l
6.20
1088
2037
461
179
29.33
307.65
1.1
1.1
1.0
1.0
u/l
0.86
182
82
623
660
11.18
307.65
1.1
1.3
3.6
3.7
mmol/l
1.90
580
619
362
174
22.99
307.65
4.2
2.0
0.3
0.2
e9/l
1.84
317
145
766
1711
5.40
307.65
3.5
1.7
1.1
1.4
g/l
4.11
751
1587
2703
14893
4.14
307.65
13.0
5.8
0.0
0.0
e9/l
0.47
2509
13065
641
645
11.84
307.65
1.2
1.4
31.5
25.9
e6/l
0.10
509
488
476
12
456.00
307.65
2.8
1.1
—
—
—
0
0
335
221
16.59
307.65
2.6
2.2
48.9
40.7
%
1.30
110
20
212
20
112.47
307.65
1.1
1.0
—
—
—
0
0
364
179
22.48
307.65
4.1
2.0
470.8
602.9
e6/l
1.45
315
144
640
645
11.82
307.65
1.2
1.4
514.6
1404.2
e6/l
0.92
524
516
634
979
7.63
307.65
1.9
1.6
52.2
0.4
iu/ml
0.59
47
200
672
230
35.58
307.65
1.1
1.1
217.5
238.1
mg/l
1.06
589
200
378
32
131.66
307.65
1.2
1.1
—
—
—
0
0
2702
14845
4.16
307.65
12.9
5.8
0.6
0.5
e9/l
0.40
2505
13043
686
242
34.68
307.65
1.2
1.2
53.4
34.1
mg/l
9.71
562
207
2711
15366
3.97
302.75
12.9
5.8
1.7
2.0
e9/l
10.44
2534
13784
2555
13987
3.76
299.88
12.7
6.1
9.0
8.2
%
43.98
2503
13196
2543
13902
3.73
298.60
12.6
5.8
3.0
2.8
%
4.96
2490
13017
271
200
14.56
294.28
3.0
2.0
—
—
—
0
0
190
68
29.42
284.26
4.7
2.5
—
—
—
0
0
2574
14503
3.63
280.78
12.6
5.9
26.4
29.2
%
34.95
2515
13627
793
2078
4.60
280.09
1.4
1.3
19.1
43.0
au/ml
—
9
96
828
2259
4.45
277.39
2.5
2.4
40.1
22.6
au/ml
1.55
21
175
2543
14313
3.56
275.80
12.2
5.7
58.9
56.6
%
20.71
2487
13492
2776
17078
3.61
248.25
14.0
8.8
3.7
4.0
e9/l
10.32
2582
15057
237
223
11.30
220.60
1.1
1.4
1.7
2.0
mmol/l
3.81
222
205
1618
7832
2.91
210.74
4.9
2.9
21.2
95.8
e6/l
3.21
1377
5911
1265
5415
3.04
205.39
3.6
2.4
4.9
7.0
e6/l
8.08
1167
4737
2153
12233
2.85
204.66
2.5
2.2
89.7
74.6
nmol/l
73.14
2021
11305
1504
7126
2.89
202.04
4.6
2.8
0.2
0.3
e6/l
6.88
1250
5286
1770
9561
2.65
178.18
5.8
3.4
76.7
78.2
e6/l
0.03
1427
6489
2778
19082
2.91
166.30
8.3
3.9
2712.5
1537.3
e6/l
0.30
37
224
2104
13191
2.40
142.60
13.8
8.5
0.0
0.0
e9/l
0.12
1827
10827
152
142
11.13
141.66
1.1
1.3
94.8
66.6
%
2.71
21
16
917
4256
2.54
117.56
4.2
2.5
0.9
1.2
e6/l
1.00
556
2316
419
1280
3.57
114.04
1.5
2.1
36.2
39.6
u/l
3.11
394
1174
105
81
13.32
110.33
1.1
1.2
3.8
15.1
%
—
18
10
2139
14505
2.15
106.91
5.9
3.3
0.0
0.0
estimate
1.08
507
2691
1761
11117
2.13
105.92
4.1
4.6
37.1
36.4
g/l
6.38
1644
10397
2155
14708
2.14
105.21
6.0
3.3
0.0
0.0
estimate
1.32
517
2693
2141
14590
2.13
104.77
7.9
4.5
0.0
0.0
estimate
0.37
519
2780
136
173
8.13
100.29
4.1
2.7
48.7
43.6
%
1.44
55
52
828
3985
2.39
95.74
4.4
2.6
5.0
3.4
e6/l
1.98
467
2054
101
136
7.61
70.87
1.2
1.7
—
—
—
0
0
1967
14178
1.84
69.06
5.4
5.9
9.8
10.6
umol/l
4.21
1885
13442
89
108
8.42
68.13
1.1
1.1
117.5
465.8
ng/l
0.78
30
20
79
83
9.71
67.57
2.0
2.1
—
—
—
0
0
207
565
3.82
65.82
4.2
3.8
60.4
56.9
%
3.71
207
565
717
3757
2.13
64.75
1.9
2.2
29.2
29.4
s
0.71
688
3636
409
1704
2.58
62.80
1.6
2.5
68.3
67.1
g/l
2.90
385
1574
99
154
6.58
60.89
1.1
1.1
—
—
—
0
0
1062
6622
1.85
57.01
2.4
1.4
2.0
2.2
g/l
5.25
798
4245
350
1456
2.55
53.61
2.6
1.7
—
—
—
0
0
1159
7563
1.78
52.73
2.3
2.1
149.3
212.2
u/l
1.93
1104
7167
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
94
162
5.93
52.23
1.1
1.1
—
—
—
0
0
2059
15832
1.69
50.73
4.6
4.4
6.2
6.5
mmol/l
9.41
1941
14581
2624
21805
1.72
45.80
7.0
7.1
74.1
74.7
u/l
0.29
2476
20642
426
2110
2.15
43.28
2.6
2.2
2473.3
5080.6
u/l
1.06
106
864
1124
7652
1.68
41.88
7.2
3.6
0.0
0.0
estimate
1.49
515
2735
282
1196
2.47
41.19
1.4
1.3
—
—
—
0
0
108
262
4.22
40.33
1.2
1.6
—
—
—
0
0
49
55
9.02
39.84
1.1
1.3
—
—
—
0
0
1540
11469
1.59
39.27
6.7
3.3
—
—
—
0
0
58
83
7.08
38.55
1.1
1.1
—
—
—
0
0
58
83
7.08
38.55
1.1
1.1
—
—
—
0
0
57
85
6.80
36.49
1.1
1.1
—
—
—
0
0
62
104
6.05
35.43
1.0
1.0
—
—
—
0
0
3340
30620
2.07
33.11
15.5
11.6
20.7
20.6
mg/l
0.12
2623
23841
93
234
4.05
33.11
1.2
1.6
—
—
—
0
0
51
81
6.37
30.77
1.1
1.1
—
—
—
0
0
1612
12625
1.50
29.94
6.1
6.2
1.2
1.2
mmol/l
2.52
1315
10727
51
85
6.07
29.35
1.1
1.1
—
—
—
0
0
2548
21974
1.53
29.03
4.4
2.9
43.3
41.0
u/l
0.69
2443
20912
3470
32552
2.34
28.06
15.6
9.1
26.7
26.2
u/l
0.85
3397
31651
3285
30240
1.86
27.77
15.1
12.1
139.6
139.7
mmol/l
0.07
3219
29483
3291
30363
1.85
26.90
15.2
12.2
3.9
3.9
mmol/l
3.95
3217
29540
257
1255
2.13
26.73
5.0
2.5
0.2
0.3
e6/l
0.07
252
1209
51
95
5.43
26.16
1.1
1.2
—
—
—
0
0
1330
10239
1.47
25.75
4.0
3.2
29.9
31.4
u/l
0.82
1288
9769
1439
11344
1.44
24.15
5.6
5.6
1.2
1.2
mmol/l
1.17
1294
10361
577
3743
1.64
24.13
1.9
1.8
—
—
—
0
0
1319
10236
1.45
24.05
1.9
1.8
95.5
98.0
pmol/l
1.11
684
5479
2920
26375
1.54
22.90
22.1
13.9
13.4
13.5
%
3.33
2882
25844
2764
30070
0.67
22.43
3.8
3.8
1.5
1.5
mmol/l
0.04
2536
28409
31
41
7.62
22.07
1.1
1.0
—
—
—
0
0
111
410
2.76
21.46
1.2
1.8
—
1200.0
—
0
14
2506
22065
1.43
21.44
3.7
3.9
10.3
10.3
mm/h
0.10
2338
20711
191
907
2.17
21.32
1.6
1.6
87.7
363.4
titre
1.56
11
35
30
41
7.37
20.77
1.1
1.0
—
—
—
0
0
2831
30531
0.68
19.97
4.1
4.1
2.9
2.9
mmol/l
0.73
2592
28762
2796
30210
0.68
19.70
3.8
3.8
4.8
4.8
mmol/l
1.14
2587
28647
2660
28993
0.70
19.55
3.4
3.5
1.3
1.3
mmol/l
0.24
2447
27309
3085
28453
1.54
19.43
13.6
10.1
93.4
88.4
ml/min/173m2
36.92
2652
23456
78
256
3.09
18.68
1.1
1.2
—
—
—
0
0
27
38
7.15
18.22
1.1
1.1
91.4
46.6
%
3.59
17
15
48
117
4.14
17.94
1.1
1.2
—
—
—
0
0
246
1371
1.85
17.47
1.2
1.3
4.4
0.9
u/ml
0.68
11
119
23
31
7.46
16.10
1.0
1.1
—
—
—
0
0
736
5488
1.43
15.40
1.6
1.5
20.4
20.7
nmol/l
0.16
641
4814
384
2509
1.59
15.22
1.7
1.7
—
—
—
0
0
156
784
2.03
15.05
1.6
2.1
7.0
7.3
g/l
1.57
120
599
156
784
2.03
15.05
1.6
2.1
—
—
—
0
0
150
746
2.05
14.90
1.5
2.1
2.9
3.1
g/l
1.66
117
582
155
783
2.02
14.75
1.6
2.1
3.5
3.8
g/l
2.05
116
565
144
711
2.07
14.59
1.6
2.2
10.0
10.4
g/l
0.39
123
616
576
4151
1.46
14.39
1.7
1.7
1087.4
1178.6
nmol/l
1.34
439
3221
25
42
5.99
14.31
1.0
1.2
—
—
—
0
0
59
194
3.07
14.17
1.0
1.1
4.3
6.2
nmol/l
—
10
32
814
6281
1.38
13.76
6.5
3.5
1.0
1.0
kg/l
0.06
117
905
382
2555
1.55
13.64
1.8
1.7
—
—
—
0
0
155
826
1.92
12.69
1.5
2.1
9.1
10.9
mg/l
2.52
148
772
211
1238
1.75
12.64
1.6
1.6
—
—
—
0
0
3037
28454
1.40
12.64
5.4
4.8
1.7
2.0
mu/l
2.08
2835
26752
1140
9364
1.32
12.51
3.3
3.0
33.4
39.7
ng/l
0.29
665
5075
123
612
2.05
12.25
1.6
2.1
39.4
38.2
g/l
1.26
109
540
17
23
7.42
11.84
1.1
1.0
—
—
—
0
0
82
356
2.33
11.49
3.0
3.1
0.6
1.5
%
4.35
70
290
113
559
2.05
11.46
1.6
2.2
0.0
0.0
g/l
0.00
104
520
120
607
2.01
11.45
1.6
2.1
0.0
0.0
g/l
0.65
111
566
178
1026
1.77
11.36
1.8
1.8
1.2
1.2
g/l
0.11
171
965
173
993
1.78
11.21
1.8
1.9
0.2
0.2
g/l
0.25
166
934
112
557
2.04
11.20
1.6
2.2
0.0
0.0
g/l
0.00
104
519
19
31
6.16
11.19
1.1
1.2
—
—
—
0
0
181
1056
1.75
11.09
2.1
2.0
—
—
—
0
0
128
671
1.94
11.04
1.6
2.3
0.5
0.8
g/l
0.53
115
601
158
899
1.79
10.56
2.0
1.8
—
—
—
0
0
15
21
7.17
10.13
1.1
1.0
—
—
—
0
0
1067
8894
1.28
10.01
2.6
3.2
2.3
2.3
mmol/l
0.24
922
7989
32
90
3.58
9.91
3.2
2.7
23.4
30.1
umol/l
1.80
22
66
260
3766
0.67
8.97
1.6
1.6
—
—
—
0
0
23
55
4.20
8.91
1.1
1.2
—
—
—
0
0
53
214
2.50
8.78
2.9
2.9
50.2
55.1
%
0.78
39
148
163
994
1.67
8.57
1.2
1.2
—
—
—
0
0
1036
8742
1.26
8.52
2.4
2.5
52.1
56.5
u/l
4.57
957
8145
289
2016
1.47
8.42
3.9
3.5
1.2
1.2
mmol/l
0.32
249
1755
49
195
2.53
8.38
1.3
1.1
1.6
29.4
u/ml
—
8
18
93
482
1.95
8.38
1.3
1.3
—
—
—
0
0
93
482
1.95
8.38
1.3
1.3
—
—
—
0
0
20
45
4.46
8.36
1.5
1.9
—
—
—
0
0
19
41
4.65
8.34
1.1
1.2
—
—
—
0
0
14
23
6.11
8.18
1.5
1.6
1.5
0.8
mg/l
—
8
14
14
24
5.85
7.85
1.1
1.0
4.8
21.6
%
—
6
5
380
2846
1.37
7.44
7.4
7.3
104.2
104.6
mmol/l
0.70
363
2782
427
3263
1.35
7.35
2.8
2.7
6.3
7.2
umol/l
0.64
372
2808
158
998
1.61
7.28
2.2
1.9
—
—
—
0
0
517
4078
1.31
7.14
3.3
3.5
0.8
0.8
mmol/l
0.31
476
3839
24
70
3.44
7.11
1.0
1.1
—
—
—
0
0
25
75
3.35
7.10
1.2
1.1
—
—
—
0
0
25
75
3.35
7.10
1.2
1.1
88.9
97.0
%
0.59
25
75
153
974
1.60
6.84
1.2
1.3
29.2
37.5
u/ml
—
8
68
250
1770
1.44
6.77
1.8
1.6
—
—
—
0
0
341
2559
1.37
6.59
2.9
4.3
226.7
240.4
u/l
1.15
322
2431
127
781
1.65
6.54
2.0
2.4
245.9
342.9
ug/l
0.58
118
714
219
1527
1.46
6.44
1.2
1.3
192.9
226.4
miu/ml
0.74
82
775
337
2536
1.36
6.41
3.8
2.8
—
—
—
0
0
20
56
3.59
6.31
1.2
1.2
—
—
—
0
0
666
5514
1.25
6.21
1.6
1.6
15817676.9
35278379.9
pmol/l
0.56
569
4731
321
2409
1.36
6.21
3.3
2.6
1.6
1.8
%
3.23
279
2151
12
23
5.23
6.00
1.4
1.6
3.5
6.1
mg/l
—
7
12
12
23
5.23
6.00
1.4
1.6
0.6
1.1
mg/l
—
7
12
12
23
5.23
6.00
1.4
1.6
1.7
2.7
mg/l
—
7
12
12
23
5.23
6.00
1.4
1.6
1.0
0.4
mg/l
—
5
12
12
23
5.23
6.00
1.4
1.6
0.9
0.7
mg/l
—
7
10
33
130
2.55
5.86
1.1
1.2
—
—
—
0
0
10
17
5.90
5.62
3.0
5.6
—
—
—
0
0
136
887
1.55
5.55
1.2
1.3
3.7
7.4
u/ml
0.99
16
136
563
4638
1.25
5.45
3.0
3.2
341.8
475.5
ng/l
0.44
324
2990
103
635
1.64
5.32
2.3
2.9
—
—
—
0
0
23
80
2.89
5.18
1.2
1.4
97.4
127.3
nmol/l
0.51
15
61
75
428
1.77
5.15
1.4
1.5
—
—
—
0
0
392
3112
1.29
5.14
4.7
5.8
1.0
1.0
mmol/l
2.09
358
2911
15
40
3.76
5.08
1.8
2.0
—
—
—
0
0
132
875
1.53
5.04
1.2
1.3
2.0
6.9
u/ml
—
8
92
29
116
2.51
5.03
1.3
1.8
9.8
13.2
u/l
2.71
29
111
3523
34613
1.51
5.01
27.2
17.0
263.4
261.1
e9/l
1.34
3482
33932
3526
34649
1.52
5.00
27.2
17.1
6.5
6.7
e9/l
3.41
3475
33903
14
36
3.90
4.98
1.0
1.0
—
—
—
0
0
3525
34643
1.51
4.93
27.2
17.0
4.5
4.5
e12/l
1.30
3478
33909
3525
34652
1.50
4.82
27.3
17.1
135.7
135.8
g/l
0.24
3501
34290
117
766
1.54
4.74
1.2
1.3
53.0
36.8
u/ml
0.42
12
74
184
1321
1.41
4.70
4.7
3.0
133.1
130.6
g/l
0.92
179
1289
2584
24586
1.17
4.60
4.5
4.1
14.7
14.5
pmol/l
5.92
2376
22946
89
556
1.62
4.43
1.2
1.3
3.1
4.2
u/ml
0.54
32
235
111
731
1.53
4.41
1.7
1.7
—
—
—
0
0
56
311
1.81
4.27
1.3
1.5
—
—
—
0
0
208
2754
0.74
4.26
1.4
1.5
—
—
—
0
0
30
134
2.25
4.15
1.4
1.6
—
—
—
0
0
189
1397
1.37
4.11
4.1
3.2
5.2
5.1
kpa
0.26
178
1315
60
1002
0.59
4.02
1.3
1.5
—
—
—
0
0
74
1173
0.62
4.00
1.5
1.8
—
—
—
0
0
181
1336
1.37
3.98
4.1
3.2
2.0
1.6
mmol/l
1.08
154
997
129
897
1.45
3.97
4.9
6.1
1.9
1.7
%
0.89
120
835
118
807
1.48
3.96
1.9
2.1
2.1
1.7
ug/l
0.16
95
727
101
1490
0.67
3.91
1.6
1.7
4.4
4.1
mg/l
0.14
66
1039
794
6975
1.18
3.90
1.7
1.8
0.8
1.0
mg/l
1.02
578
5185
11
29
3.80
3.80
1.0
1.2
—
—
—
0
0
142
1015
1.42
3.79
3.3
3.2
25.9
25.3
mmol/l
1.27
134
981
82
525
1.57
3.74
2.4
3.2
32.2
34.7
umol/l
0.47
67
461
61
365
1.68
3.65
1.3
1.4
—
—
—
0
0
25
110
2.28
3.61
1.3
1.3
—
—
—
0
0
87
572
1.53
3.55
1.1
1.2
2.0
3.7
u/ml
1.32
25
189
295
2373
1.26
3.53
2.5
2.3
0.2
0.2
g/l
0.29
280
2236
88
582
1.52
3.50
3.3
5.8
324.4
418.6
iu/ml
—
5
70
101
688
1.48
3.50
1.2
1.3
0.9
3.2
u/ml
—
7
50
90
599
1.52
3.48
1.4
1.3
—
—
—
0
0
124
880
1.42
3.47
4.7
3.3
25.3
24.8
mmol/l
1.30
118
821
357
2945
1.24
3.43
2.0
2.1
353.6
372.3
nmol/l
1.14
325
2730
132
951
1.40
3.40
1.5
1.9
1.4
1.5
g/l
0.70
113
827
254
2018
1.28
3.38
5.0
3.6
5.9
5.9
kpa
0.21
244
1955
25
114
2.20
3.34
1.3
1.3
—
—
—
0
0
252
2004
1.28
3.33
5.0
3.7
2.1
1.9
mmol/l
0.57
218
1621
244
1933
1.28
3.32
6.9
8.1
6.8
8.3
mmol/l
5.12
232
1857
330
2710
1.24
3.31
2.6
2.4
34.7
54.9
u/l
0.57
275
2345
38
204
1.87
3.29
1.1
1.2
—
—
—
0
0
36
191
1.89
3.24
1.2
1.6
5.3
5.8
u/l
0.43
29
160
481
4112
1.20
3.23
2.2
2.4
13.7
14.1
umol/l
0.45
440
3814
50
295
1.70
3.19
1.7
2.1
20.8
22.1
mg/l
0.08
16
81
11
33
3.34
3.19
1.0
1.1
5.1
82.7
ug/l
—
6
14
40
223
1.80
3.10
1.1
1.0
—
—
—
0
0
53
321
1.66
3.08
1.4
1.5
—
—
—
0
0
640
5628
1.17
3.07
2.5
2.8
738.9
919.2
ng/l
1.11
537
4653
189
1471
1.30
2.98
1.6
1.5
—
—
—
0
0
763
6814
1.15
2.97
2.2
2.1
2.9
2.8
mg/l
0.25
658
5872
13
324
0.40
2.95
1.3
1.3
32.0
32.7
nmol/l
0.03
13
284
63
404
1.57
2.93
1.1
1.1
1.5
1.5
g/l
0.11
56
368
137
1809
0.75
2.84
1.4
1.4
—
—
—
0
0
48
291
1.66
2.81
1.4
1.6
—
—
—
0
0
692
7739
0.87
2.79
3.7
3.2
7.7
7.8
mmol/l
0.08
587
6662
435
3740
1.19
2.75
2.2
2.3
2.4
2.4
g/l
0.28
398
3470
70
468
1.51
2.73
2.4
2.3
16.9
16.8
%
0.08
33
229
140
1060
1.33
2.71
1.3
1.4
—
—
—
0
0
2574
26615
0.89
2.68
4.6
4.7
37.9
38.4
mmol/mol
2.65
2384
25133
366
3106
1.20
2.68
3.8
3.8
31.2
31.8
%
0.53
273
2241
154
1983
0.77
2.68
1.3
1.4
—
—
—
0
0
67
447
1.51
2.65
1.7
1.7
—
—
—
0
0
302
2522
1.22
2.63
7.7
8.3
1.2
1.0
mmol/l
0.26
229
1961
355
3012
1.20
2.61
6.8
5.7
—
—
—
0
0
24
120
2.01
2.60
1.1
1.2
94.5
92.8
%
—
6
49
302
2525
1.21
2.60
7.7
8.2
5.0
5.1
kpa
0.42
286
2416
302
2525
1.21
2.60
7.7
8.2
12.6
12.9
kpa
0.38
287
2417
25
127
1.98
2.60
1.1
1.1
84.7
92.0
%
—
7
52
46
728
0.63
2.59
1.0
1.1
0.4
1.6
u/ml
—
10
178
124
932
1.34
2.54
2.1
2.5
158.8
176.2
%
1.61
117
883
628
7024
0.87
2.52
4.5
4.0
9.2
9.3
mg/mmol
0.01
396
4488
38
624
0.60
2.51
1.1
1.2
—
—
—
0
0
202
1628
1.25
2.46
5.0
3.0
5.0
4.7
kpa
0.92
191
1568
30
167
1.80
2.40
1.4
1.6
—
—
—
0
0
23
117
1.97
2.40
1.6
1.6
—
—
—
0
0
40
640
0.62
2.38
1.1
1.1
1.8
3.3
u/ml
0.76
18
244
77
541
1.43
2.38
2.8
3.0
25.0
24.7
mmol/l
0.24
70
487
33
190
1.74
2.37
3.2
1.8
2.3
1.7
u/field
0.30
16
98
847
7724
1.13
2.36
1.3
1.3
1.0
1.5
u/ml
1.04
204
2210
120
910
1.33
2.35
2.2
2.0
7.1
4.2
iu/l
1.35
47
360
790
7177
1.13
2.34
1.6
1.5
—
—
—
0
0
67
461
1.46
2.32
1.4
1.6
—
—
—
0
0
60
873
0.68
2.29
1.1
1.1
1.1
1.3
u/ml
0.09
19
345
19
92
2.07
2.27
1.3
1.3
—
—
—
0
0
19
92
2.07
2.27
1.3
1.3
—
—
—
0
0
99
1314
0.75
2.20
1.4
1.5
—
—
—
0
0
240
2002
1.21
2.16
8.9
7.4
1.2
1.3
mmol/l
0.68
228
1925
9
30
3.00
2.14
2.0
2.5
0.7
0.9
u/field
—
9
30
49
322
1.53
2.13
1.3
1.4
—
—
—
0
0
49
322
1.53
2.13
1.3
1.4
—
—
—
0
0
393
3428
1.16
2.12
2.3
2.4
23.0
23.8
%
0.49
327
2956
62
429
1.45
2.11
1.7
1.6
—
—
—
0
0
49
323
1.52
2.11
1.3
1.4
—
—
—
0
0
22
116
1.90
2.10
1.6
1.6
—
—
—
0
0
38
236
1.62
2.10
1.2
1.3
242.9
221.2
titre
—
7
51
49
324
1.52
2.08
1.3
1.4
—
—
—
0
0
39
245
1.60
2.06
1.3
1.5
12.6
11.3
umol/l
0.56
39
229
7
20
3.50
2.05
1.0
1.1
8.1
21.7
u/l
—
7
20
6
15
4.00
2.04
1.2
1.1
—
—
—
0
0
49
326
1.51
2.03
1.3
1.4
—
—
—
0
0
26
148
1.76
1.98
1.4
1.3
15.8
20.1
u/ml
—
8
28
42
272
1.55
1.97
1.3
1.1
—
—
—
0
0
42
272
1.55
1.97
1.3
1.1
—
—
—
0
0
42
272
1.55
1.97
1.3
1.1
—
—
—
0
0
49
329
1.50
1.96
1.3
1.4
—
—
—
0
0
5
11
4.55
1.94
2.2
1.1
—
—
—
0
0
126
1587
0.79
1.92
1.4
1.5
—
—
—
0
0
77
565
1.37
1.92
3.5
3.4
27.8
37.8
mg/l
0.79
65
456
77
565
1.37
1.92
3.5
3.4
35.9
63.3
mg/l
1.16
65
455
50
339
1.48
1.91
1.4
1.4
304.4
310.8
pmol/l
0.03
34
267
507
5643
0.88
1.89
1.2
1.3
3.6
9.4
u/ml
4.33
199
2398
35
543
0.64
1.89
1.5
1.4
5.9
7.1
mmol/l
2.80
23
395
7
22
3.19
1.88
2.0
2.2
—
—
—
0
0
144
1157
1.25
1.87
10.4
10.5
24.6
24.3
mmol/l
0.63
139
1093
149
1202
1.25
1.87
9.9
11.5
—
—
—
0
0
108
1381
0.78
1.87
2.1
2.0
—
—
—
0
0
41
268
1.54
1.86
1.3
1.1
—
—
—
0
0
41
268
1.54
1.86
1.3
1.1
—
—
—
0
0
78
577
1.36
1.86
1.4
1.6
—
—
—
0
0
16
79
2.03
1.85
1.3
1.9
9.3
49.2
u/l
1.14
11
73
103
795
1.30
1.84
1.3
1.4
27.3
24.7
u/l
0.34
77
669
44
293
1.51
1.84
1.3
1.4
—
—
—
0
0
6
17
3.53
1.83
1.0
1.3
—
—
—
0
0
40
596
0.67
1.79
1.1
1.1
2.5
3.3
u/ml
0.22
13
240
247
2109
1.18
1.77
8.6
9.1
123.2
122.8
g/l
0.12
234
2032
5
136
0.37
1.75
3.0
2.4
—
107.1
—
0
20
118
1475
0.79
1.72
1.3
1.4
—
—
—
0
0
192
2281
0.83
1.71
3.8
4.1
5.1
39.3
ug/l
1.44
148
1759
118
938
1.27
1.71
4.7
3.6
49.7
50.0
%
0.04
113
926
118
1470
0.80
1.67
1.3
1.4
—
—
—
0
0
493
4449
1.12
1.65
2.5
2.7
2.4
2.4
mmol/l
0.61
416
3907
119
1476
0.80
1.63
1.3
1.4
—
—
—
0
0
119
1475
0.80
1.62
1.3
1.4
—
—
—
0
0
2823
28814
0.91
1.59
3.8
3.8
5.7
5.8
mmol/l
2.31
2591
26888
58
783
0.74
1.53
1.4
1.4
0.4
0.4
nmol/l
0.01
43
634
73
554
1.32
1.52
3.5
3.4
1.2
1.6
ratio
—
6
53
14
258
0.54
1.52
1.1
1.2
0.0
0.5
u/ml
—
6
91
23
138
1.67
1.51
2.8
2.4
60.5
50.5
umol/l
0.96
23
117
76
584
1.31
1.46
1.4
1.6
—
—
—
0
0
7
28
2.50
1.45
2.0
2.0
—
—
—
0
0
14
73
1.92
1.43
1.1
1.1
—
—
—
0
0
39
553
0.70
1.41
2.1
2.6
71.4
104.9
ug/min
0.34
25
342
2346
24082
0.93
1.40
3.4
3.5
—
—
—
0
0
38
263
1.45
1.38
1.2
1.7
—
—
—
0
0
660
7104
0.91
1.33
2.2
2.3
2362.0
3539.0
umol/l
0.58
576
6331
40
283
1.42
1.31
1.1
1.1
—
—
—
0
0
15
83
1.81
1.31
3.1
2.1
11.7
16.2
umol/l
1.06
15
83
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
17
99
1.72
1.27
1.2
1.2
35.5
10.8
u/l
0.52
17
90
17
100
1.70
1.23
2.9
2.4
—
—
—
0
0
122
1016
1.21
1.23
2.0
2.3
98.7
94.3
%
1.56
115
938
58
442
1.32
1.23
4.2
5.8
384.8
369.9
umol/l
0.29
47
386
5
19
2.63
1.21
1.0
1.2
—
—
—
0
0
205
1788
1.16
1.21
3.4
3.7
73.2
79.3
ng/l
0.51
177
1599
25
164
1.53
1.20
1.3
1.4
29815.9
65455.7
e6/l
0.40
12
92
35
247
1.42
1.18
1.6
1.8
—
—
—
0
0
43
315
1.37
1.18
1.5
1.6
—
—
—
0
0
0
34
0.00
1.16
0.0
2.0
—
62.9
—
0
29
74
589
1.26
1.15
1.2
1.3
—
—
—
0
0
13
73
1.78
1.10
2.7
4.7
—
—
—
0
0
17
104
1.64
1.09
1.2
1.3
—
—
—
0
0
25
169
1.48
1.07
1.6
1.6
3.0
6.0
u/l
0.68
11
92
17
105
1.62
1.06
3.6
3.2
—
—
—
0
0
232
2601
0.88
1.05
1.3
1.3
28.7
26.9
iu/l
0.34
212
2255
468
4332
1.09
1.02
2.1
2.4
124.1
107.5
ug/g
0.35
342
3468
704
7469
0.93
1.01
1.5
1.6
1.4
1.4
mmol/l
0.01
582
6458
10
53
1.89
1.01
1.1
1.2
—
—
—
0
0
27
188
1.44
1.01
1.3
1.4
38741.4
3035.0
e6/l
0.45
18
128
37
273
1.36
1.00
1.2
1.2
42.6
58.7
u/l
1.37
24
184
14
84
1.67
0.97
1.1
1.1
—
—
—
0
0
25
174
1.44
0.95
1.1
1.3
5.4
6.3
mmol/l
0.93
25
159
33
242
1.37
0.94
1.2
1.1
1.1
1.0
ratio
0.72
11
88
256
2311
1.12
0.93
3.3
3.4
4.4
4.5
pmol/l
0.84
224
2069
52
410
1.27
0.91
1.5
1.7
—
—
—
0
0
262
2884
0.90
0.89
2.6
2.7
0.6
0.7
ug/l
1.85
173
1698
34
254
1.34
0.88
1.3
1.1
—
—
—
0
0
40
307
1.31
0.87
8.5
6.7
10.8
11.1
mg/l
0.17
34
281
52
415
1.26
0.84
1.3
1.2
—
—
—
0
0
156
1377
1.14
0.84
6.7
7.9
24.3
24.4
mmol/l
0.05
142
1280
6
31
1.94
0.84
1.2
1.1
—
—
—
0
0
118
1022
1.16
0.83
1.1
1.1
1.1
4.3
u/ml
2.57
12
153
70
580
1.21
0.82
1.0
1.1
—
—
—
0
0
1534
14895
1.05
0.80
2.9
2.9
104.9
92.3
ug/l
1.24
1446
14066
31
234
1.33
0.77
3.6
2.3
—
—
—
0
0
18
123
1.47
0.77
1.3
1.2
—
—
—
0
0
67
802
0.83
0.77
3.1
3.6
523.5
1700.3
u/ml
0.42
57
684
12
185
0.65
0.75
1.1
1.4
97.2
226.5
pmol/l
—
6
59
44
352
1.25
0.73
1.1
1.2
—
—
—
0
0
31
400
0.77
0.71
1.5
1.6
7.5
7.6
mmol/l
0.10
19
250
55
453
1.22
0.71
1.5
1.2
—
—
—
0
0
29
221
1.31
0.69
1.2
2.0
—
—
—
0
0
22
297
0.74
0.69
1.5
1.5
—
—
—
0
0
121
1069
1.14
0.68
6.6
3.9
24.5
24.2
mmol/l
0.69
111
969
1357
13948
0.96
0.65
4.0
3.8
—
—
—
0
0
54
452
1.20
0.61
1.3
1.1
—
—
—
0
0
255
2363
1.09
0.61
1.2
1.3
128.5
185.6
u/ml
1.01
234
2196
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
63
735
0.85
0.58
1.2
1.3
2.5
3.7
ug/l
1.61
57
675
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
48
573
0.84
0.58
2.6
2.4
0.9
0.8
nmol/l
0.07
36
494
6
36
1.67
0.56
1.0
1.0
—
—
—
0
0
6
37
1.62
0.55
1.0
1.0
—
—
—
0
0
515
4912
1.06
0.55
3.7
4.1
1.6
2.0
ug/l
2.45
459
4455
10
148
0.67
0.55
1.6
2.3
28.1
361.2
ug/l
—
10
135
62
719
0.86
0.54
1.1
1.2
—
—
—
0
0
8
122
0.66
0.54
1.1
1.0
—
—
—
0
0
155
1697
0.91
0.54
1.7
1.6
327.6
294.9
mu/l
0.48
139
1514
63
729
0.86
0.54
1.9
3.3
1.3
1.4
mg/l
0.29
55
687
15
205
0.73
0.54
1.6
1.9
—
—
—
0
0
9
62
1.45
0.53
1.0
1.2
—
—
—
0
0
54
630
0.85
0.52
1.9
2.1
4.5
4.9
umol/l
0.25
41
452
22
278
0.79
0.47
1.4
1.4
0.8
1.0
g/l
0.80
22
278
42
355
1.19
0.47
1.3
1.3
—
31.6
—
0
7
293
2766
1.06
0.46
1.3
1.2
165.5
163.2
iu/ml
0.03
124
1067
27
220
1.23
0.43
1.2
1.3
—
—
—
0
0
64
564
1.14
0.43
5.5
3.3
24.4
22.5
mg/l
0.12
35
350
75
668
1.13
0.43
3.7
4.3
3.8
3.8
mmol/l
0.02
66
627
174
1619
1.08
0.42
2.3
2.9
99.1
149.2
ng/l
2.64
148
1442
21
261
0.80
0.41
13.2
18.9
890.6
5185.0
nmol/l
0.62
16
252
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
8.1
—
0
17
31
369
0.84
0.40
1.4
1.5
—
—
—
0
0
287
2723
1.06
0.40
15.3
17.9
1.1
1.2
inr
0.84
59
413
17
132
1.29
0.40
1.2
1.0
771.4
744.2
ng/l
0.08
11
85
17
132
1.29
0.40
1.2
1.0
204.7
289.9
ng/l
1.67
11
88
0
18
0.00
0.40
0.0
1.4
—
5203.0
—
0
13
5
35
1.43
0.39
1.0
1.9
—
—
—
0
0
186
1747
1.07
0.37
1.9
2.2
12.4
12.1
nmol/l
0.19
167
1563
5
37
1.35
0.37
1.0
1.1
1.3
1.7
umol/24h
—
5
37
17
134
1.27
0.36
1.2
1.0
26.3
42.1
ng/l
2.35
11
86
204
1928
1.06
0.34
1.1
1.1
—
—
—
0
0
30
258
1.16
0.31
3.1
2.2
32.6
32.0
pg
0.50
30
258
57
514
1.11
0.30
2.5
2.1
130.0
131.6
g/l
0.21
48
377
14
112
1.25
0.28
1.1
1.6
—
—
—
0
0
14
112
1.25
0.28
1.1
1.6
—
—
—
0
0
46
511
0.90
0.27
1.1
1.1
4.4
16987.0
iu/ml
0.54
12
138
61
557
1.10
0.27
1.1
1.1
—
—
—
0
0
87
933
0.93
0.25
1.2
1.1
—
—
—
0
0
13
105
1.24
0.24
1.4
1.2
—
—
—
0
0
69
746
0.92
0.24
1.8
1.6
—
—
—
0
0
11
137
0.80
0.24
1.2
1.1
—
—
—
0
0
9
77
1.17
0.24
1.8
3.4
—
—
—
0
0
9
77
1.17
0.24
1.8
3.4
—
—
—
0
0
16
133
1.20
0.24
1.4
1.7
—
—
—
0
0
16
133
1.20
0.24
1.4
1.7
—
—
—
0
0
16
133
1.20
0.24
1.4
1.7
—
—
—
0
0
16
133
1.20
0.24
1.4
1.7
—
—
—
0
0
10
126
0.79
0.24
1.0
1.0
—
—
—
0
0
79
738
1.07
0.22
1.2
1.2
—
—
—
0
0
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
70
652
1.08
0.21
1.2
1.4
165.4
109.9
u/ml
0.44
14
144
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
12.7
—
—
—
0
0
19
220
0.86
0.21
3.4
2.7
—
—
—
0
0
19
220
0.86
0.21
1.6
1.5
29.7
34.2
%
0.26
12
132
75
701
1.07
0.21
1.2
1.2
303.7
265.1
u/ml
0.36
44
462
670
6826
0.98
0.20
2.2
2.1
—
—
—
0
0
526
5147
1.03
0.20
1.9
2.0
—
—
—
0
0
6
48
1.25
0.20
1.0
1.3
—
—
—
0
0
31
278
1.12
0.20
1.1
1.1
—
—
—
0
0
6
49
1.22
0.20
1.3
1.3
—
—
—
0
0
169
1624
1.04
0.19
1.5
1.5
—
—
—
0
0
63
588
1.07
0.19
1.1
1.0
1.3
3.4
u/ml
2.60
24
305
47
509
0.92
0.19
1.1
1.2
—
—
—
0
0
89
940
0.95
0.18
1.2
1.1
—
—
—
0
0
428
4372
0.98
0.17
1.8
1.8
1.5
1.4
%
1.96
390
3923
79
747
1.06
0.17
1.5
1.4
290.2
300.3
ug/g
0.14
39
390
163
1576
1.04
0.15
1.4
1.5
—
—
—
0
0
62
657
0.94
0.15
1.8
1.8
—
—
—
0
0
56
594
0.94
0.14
1.4
1.7
8796.3
9889.6
e6/l
0.12
39
429
382
3893
0.98
0.14
3.3
3.6
21.1
21.2
%
0.05
153
1587
39
363
1.08
0.13
1.1
1.2
14.7
36.0
u/l
1.80
34
315
27
247
1.09
0.13
1.3
1.1
—
—
—
0
0
24
219
1.10
0.12
1.3
1.6
—
—
—
0
0
24
219
1.10
0.12
1.3
1.6
—
—
—
0
0
24
219
1.10
0.12
1.3
1.6
—
—
—
0
0
187
1920
0.97
0.12
1.9
2.8
25.3
42.9
u/ml
2.41
181
1862
756
7644
0.99
0.12
1.6
1.6
—
—
—
0
0
346
3517
0.98
0.11
1.9
1.9
—
—
—
0
0
113
1166
0.97
0.11
1.2
1.3
11.9
10.7
u/l
0.39
92
981
586
5793
1.01
0.10
2.1
2.1
—
—
—
0
0
2943
29500
0.99
0.10
19.1
12.2
39.9
40.2
%
1.08
2171
23591
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
657
0.96
0.10
7.1
3.7
0.4
0.3
u/ml
0.43
35
368
5
45
1.11
0.09
1.0
1.3
—
—
—
0
0
587
5930
0.99
0.09
1.3
1.3
16.7
27.3
iu/ml
2.42
136
1877
32
302
1.06
0.08
1.2
1.4
9.5
12.9
mmol/l
1.97
11
59
6
58
1.03
0.08
1.7
1.6
—
—
—
0
0
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
17
185
0.92
0.08
2.3
1.3
—
—
—
0
0
17
184
0.92
0.07
1.5
1.6
—
—
—
0
0
9
85
1.06
0.07
1.1
1.2
—
—
—
0
0
58
561
1.03
0.06
1.6
1.8
227.6
197.9
pmol/l
0.99
53
525
21
198
1.06
0.05
3.3
3.7
—
—
—
0
0
12
110
1.09
0.05
1.5
1.8
—
—
—
0
0
12
110
1.09
0.05
1.5
1.8
—
—
—
0
0
23
240
0.96
0.03
2.0
1.7
—
—
—
0
0
272
2706
1.01
0.02
1.8
1.8
—
—
—
0
0
16
153
1.05
0.01
1.5
2.8
276.7
183.3
umol/l
—
7
83
23
223
1.03
0.01
1.2
1.2
—
—
—
0
0
36
367
0.98
0.01
3.9
4.5
19.4
74.2
u/ml
—
8
104
176
1752
1.00
0.01
2.0
2.2
6.0
6.9
ug/l
0.42
150
1559
17
176
0.97
0.00
1.8
1.9
—
—
—
0
0
23
224
1.03
0.00
1.2
1.4
20330.3
62815.2
e6/l
0.71
17
153
29
296
0.98
0.00
1.7
1.6
46.6
58.1
%
0.78
21
181
117
1176
0.99
0.00
1.8
1.8
—
—
—
0
0
10
102
0.98
0.00
1.9
1.5
9.1
8.1
ug/l
—
10
102
12
118
1.02
0.00
1.0
1.2
—
—
—
0
0
219
2192
1.00
0.00
1.9
2.4
79.0
73.2
ml/min/173m2
1.61
90
818
11
111
0.99
0.00
1.5
1.8
—
—
—
0
0
18
179
1.01
0.00
1.9
1.8
—
—
—
0
0
25
251
1.00
0.00
2.4
1.6
1.2
1.3
promille
0.11
20
201
65
649
1.00
0.00
1.3
1.4
—
—
—
0
0
31
314
0.99
0.00
1.1
1.1
—
—
—
0
0
24
244
0.98
0.00
1.3
1.5
—
—
—
0
0
23
233
0.99
0.00
1.2
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
1033.4
—
0
9
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
23
230
1.00
0.00
1.2
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
29.5
—
0
8
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
8
84
0.95
0.00
2.1
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: G6_DEMYEL – Demyelinating diseases of the central nervous system
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).